• Journal Article

Economic benefit-cost analysis of select secondary prevention interventions in lMIC

Citation

Nugent, R., & Brouwer, E. (2015). Economic benefit-cost analysis of select secondary prevention interventions in lMIC. Global Heart, 10(4), 319-321. DOI: 10.1016/j.gheart.2015.09.002

Abstract

We present a quantitative economic benefit-cost analysis of 2 secondary prevention targets that are part of the World Health Organization's Global Monitoring Framework for noncommunicable diseases (NCD). These targets are expected to contribute to the achievement of the overall NCD target proposed for the Post-2015 Sustainable Development Goal Framework. We estimate that interventions would need to avert roughly 6 million to 7 million NCD deaths worldwide in 2030 to meet the target. We calculate that the combination of tobacco taxation that achieves 50% reduction in use and 70% coverage of high-risk populations with a multidrug regimen can provide one-half of that mortality reduction in 2030, at a benefit-cost ratio of 7:1, or U.S. $7 in benefits for each U.S. $1 in cost.